Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

A new type of nerve cell involved in itch perception was discovered.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

IL-1β inhibits human hair follicle growth.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Mice with human skin protein K8 had more skin problems and cancer.

IL-15 promotes hair growth and protects hair follicles.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

Topical tacrolimus reduces certain growth factors in hair follicles.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Ift20 is essential for hair follicle function and skin cell movement.

ILK is essential for skin development, pigmentation, and healing.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.